Albert Bourla Pfizer CEO Bourla
Pharma

Pfizer CEO Albert Bourla earns 2025 pay bump to $27.6M

The CEO's 2025 pay was a sizeable bump over the $24.6 million he collected in 2024.
Zoey Becker Mar 13, 2026 11:26am
fourth quarter Q4

Lilly shines in Q4 as peers brace for 2026 slowdown

Mar 11, 2026 3:00pm
Uniting for patients Helping more Americans navigate access and afford their healthcare

Uniting for patients: Navigating, accessing, and affording care

Brought to you by Patient Advocate Foundation
Collage poster study of businessmen picture chart arrow goes up

Orphan drug sales to surge past $400B in 2032: report

Mar 12, 2026 8:20am
concept of two individuals in a dispute

Bayer found to have discredited industry after Roche row

Mar 13, 2026 11:45am
GSK Arexvy

FDA signs off on GSK's Arexvy for at-risk adults ages 18-49

Mar 13, 2026 11:07am
More News

Manufacturing is key to Gilead's Yeztugo PrEP rollout: exec

Mar 13, 2026 10:33am

Patent expirations push biopharma industry toward a tougher 2026

Mar 13, 2026 9:49am

Manufactuing issues prompt FDA rejection of Hyloris antiviral

Mar 13, 2026 8:40am

Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia

Mar 13, 2026 8:05am